Showing results (1201-1210 of 4,138) with videos related to
Sort By:
Pageof 414
Human Gene Therapy|February 9, 2026
Preferential Encapsulation of DNA Impurities Derived from pAAV Plasmid Backbone into Recombinant Adeno-Associated Virus CapsidsYuzhe Yuan, Kiyoko Higashiyama, Emi Ito-Kudo, et al.Human Gene Therapy|February 4, 2026
Less Invasive Light Irradiation Methods for Inner Ear Gene Therapy Based on Photoswitch Technology: Toward Clinical TranslationMasao Noda, Takahiro Otabe, Ryota Koshu, et al.Human Gene Therapy|January 27, 2026
Advances in Precision Editing Therapies for Alpha-1 Antitrypsin DeficiencyJenny Gao, Erik Sontheimer, Terence R Flotte, et al.Human Gene Therapy|February 27, 1999
DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscleH H Chen, L M Mack, S Y Choi, et al.Human Gene Therapy|February 27, 1999
A novel tetracycline-inducible viral replication switchF Yao, E ErikssonHuman Gene Therapy|February 18, 1999
Delivery of recombinant gene products to the central nervous system with nonautologous cells in alginate microcapsulesC J Ross, M Ralph, P L ChangHuman Gene Therapy|April 21, 1999
Early cell loss after angioplasty results in a disproportionate decrease in percutaneous gene transfer to the vessel wallA Rivard, Z Luo, H Perlman, et al.Human Gene Therapy|April 21, 1999
Successful culture and sustainability in vivo of gene-modified human oral mucosal epitheliumH Mizuno, N Emi, A Abe, et al.Human Gene Therapy|December 13, 2003
Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectorsR S Everett, B L Hodges, E Y Ding, et al.Human Gene Therapy|December 13, 2003
Comparison of murine leukemia virus, human immunodeficiency virus, and adeno-associated virus vectors for gene transfer in multiple myeloma: lentiviral vectors demonstrate a striking capacity to transduce low-proliferating primary tumor cellsJohn De Vos, Claude Bagnis, Lydie Bonnafoux, et al.Pageof 414